CellaVision CEVI.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

200.00

+0.50%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 759.0m

FY2016FY2025

Net income

SEK 153.1m

FY2016FY2025

Free cash flow

SEK 181.7m

FY2016FY2025

Shareholders' equity

SEK 887.6m

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	SEK 759.0m	SEK 723.2m	SEK 677.3m	SEK 639.3m	SEK 565.6m	SEK 471.4m	SEK 461.8m	SEK 364.8m	SEK 309.3m	SEK 265.0m
Gross profit	SEK 519.9m	SEK 487.1m	SEK 463.0m	SEK 438.3m	SEK 392.3m	SEK 313.0m	SEK 336.7m	SEK 270.9m	SEK 223.2m	SEK 188.9m
Research and development	SEK 97.6m	SEK 87.4m	SEK 83.3m	SEK 88.6m	SEK 64.2m	SEK 51.3m	SEK 56.4m	SEK 39.3m	SEK 26.8m	SEK 29.2m
Operating income	SEK 202.1m	SEK 177.7m	SEK 167.1m	SEK 158.3m	SEK 162.7m	SEK 110.3m	SEK 127.9m	SEK 111.7m	SEK 90.9m	SEK 67.2m
Net income	SEK 153.1m	SEK 140.7m	SEK 130.3m	SEK 118.3m	SEK 125.3m	SEK 89.5m	SEK 99.2m	SEK 88.7m	SEK 69.7m	SEK 59.8m
Diluted earnings per share	6.42	5.90	5.46	4.96	5.25	3.75	4.16	3.72	2.92	2.51

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	SEK 1.09bn	SEK 1.01bn	SEK 928.7m	SEK 891.7m	SEK 825.2m	SEK 668.0m	SEK 641.7m	SEK 372.8m	SEK 300.6m	SEK 256.4m
Cash and short-term investments	SEK 188.2m	SEK 149.4m	SEK 121.6m	SEK 108.1m	SEK 130.3m	SEK 102.3m	SEK 102.3m	SEK 169.1m	SEK 154.5m	SEK 132.5m
Total liabilities	SEK 207.3m	SEK 196.2m	SEK 212.3m	SEK 250.1m	SEK 281.9m	SEK 238.4m	SEK 293.3m	SEK 82.4m	SEK 59.7m	SEK 50.3m
Debt	SEK 25.7m	SEK 26.9m	SEK 64.7m	SEK 102.5m	SEK 136.7m	SEK 132.8m	SEK 173.7m	—	—	—
Shareholders' equity	SEK 887.6m	SEK 815.7m	SEK 716.4m	SEK 641.6m	SEK 543.3m	SEK 429.6m	SEK 348.4m	SEK 290.4m	SEK 240.9m	SEK 206.2m
Shares outstanding	24m	24m	24m	24m	24m	24m	24m	24m	24m	24m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	SEK 200.5m	SEK 198.4m	SEK 196.4m	SEK 137.3m	SEK 159.7m	SEK 71.1m	SEK 126.0m	SEK 74.1m	SEK 87.9m	SEK 76.6m
Capital spending	−SEK 18.8m	−SEK 12.0m	−SEK 86.5m	−SEK 69.4m	−SEK 84.3m	−SEK 33.7m	−SEK 18.7m	−SEK 22.0m	−SEK 29.1m	−SEK 14.2m
Free cash flow	SEK 181.7m	SEK 186.4m	SEK 110.0m	SEK 67.9m	SEK 75.4m	SEK 37.5m	SEK 107.3m	SEK 52.1m	SEK 58.8m	SEK 62.4m
Dividends paid	−SEK 59.6m	−SEK 53.7m	−SEK 53.7m	−SEK 47.7m	−SEK 17.9m	−SEK 17.9m	−SEK 35.8m	−SEK 35.8m	−SEK 35.8m	−SEK 35.8m

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	SEK 199.9m	SEK 166.4m	SEK 197.2m	SEK 175.6m	SEK 191.3m	SEK 194.8m	SEK 186.7m	SEK 178.7m
Gross profit	SEK 140.8m	SEK 114.0m	SEK 131.8m	SEK 121.3m	SEK 129.6m	SEK 137.2m	SEK 129.2m	SEK 121.3m
Operating income	SEK 41.2m	SEK 28.5m	SEK 55.1m	SEK 39.5m	SEK 50.3m	SEK 57.1m	SEK 51.3m	SEK 38.4m
Net income	SEK 32.6m	SEK 22.5m	SEK 42.6m	SEK 31.3m	SEK 37.6m	SEK 41.5m	SEK 40.9m	SEK 31.1m
Diluted earnings per share	1.37	0.94	1.79	1.31	1.58	1.74	1.72	1.30
Cash from operations	SEK 29.0m	SEK 62.0m	SEK 51.0m	SEK 29.0m	SEK 58.0m	SEK 61.0m	SEK 45.0m	SEK 40.0m
Capital spending	−SEK 2.0m	−SEK 16.0m	−SEK 18.0m	−SEK 22.0m	−SEK 24.0m	−SEK 61.0m	−SEK 25.0m	−SEK 16.0m
Free cash flow	SEK 27.0m	SEK 46.0m	SEK 33.0m	SEK 7.0m	SEK 34.0m	SEK 0	SEK 20.0m	SEK 24.0m
Total assets	SEK 1.14bn	SEK 1.13bn	SEK 1.09bn	SEK 1.08bn	SEK 1.05bn	SEK 1.04bn	SEK 1.01bn	SEK 983.8m
Cash and short-term investments	SEK 172.2m	SEK 230.2m	SEK 188.2m	SEK 158.7m	SEK 155.3m	SEK 182.3m	SEK 149.4m	SEK 137.7m
Debt	SEK 52.3m	SEK 22.4m	SEK 25.7m	SEK 27.3m	SEK 30.2m	SEK 23.0m	SEK 26.9m	SEK 35.4m
Shareholders' equity	SEK 885.9m	SEK 914.3m	SEK 887.6m	SEK 851.5m	SEK 822.9m	SEK 838.5m	SEK 815.7m	SEK 767.9m

Financial ratios

Data as of 21 Oct 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Gross margin	68.5%	67.3%	68.4%	68.6%	69.4%	66.4%
Operating margin	27.0%	25.6%	24.7%	23.6%	28.3%	23.4%
Net margin	20.2%	19.5%	19.2%	18.5%	22.2%	19.0%
Return on equity	17.2%	17.3%	18.2%	18.4%	23.1%	20.8%
Return on assets	14.0%	13.9%	14.0%	13.3%	15.2%	13.4%
Free cash flow yield	5.1%	5.1%	5.0%	3.5%	4.1%	1.8%
Revenue growth	4.9%	6.8%	5.9%	13.0%	20.0%	2.1%
Earnings growth	8.8%	8.0%	10.1%	-5.6%	40.1%	-9.8%
Current ratio	3.98x	3.72x	3.07x	2.83x	2.71x	2.86x
Debt to equity	0.03x	0.03x	0.09x	0.16x	0.25x	0.33x
Equity ratio	81.1%	80.6%	77.1%	72.0%	65.8%	64.3%
Interest coverage	19.14x	22.68x	51.37x	64.43x	85.83x	43.31x
R&D as a share of sales	12.9%	12.1%	12.3%	13.9%	11.4%	10.9%
Buybacks as a share of market value	0.0%	0.1%	-0.1%	0.0%	0.0%	0.0%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	5.9%	10.0%	12.2%
Operating income	8.5%	12.9%	11.9%
Net income	9.0%	11.3%	11.2%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	67.9%	68.2%	68.1%	69.5%
Operating margin	25.6%	25.2%	25.5%	26.3%
Net margin	19.8%	19.4%	19.7%	20.6%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	24.4	36.9	38.8	46.2	61.9	82.6	76.8	51.5	49.2	34.3
Price to sales	4.9	7.2	7.5	8.5	13.7	15.7	16.5	12.5	11.1	7.7

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 29 Apr 2026.

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2019	FY2018
Paid in the year	2.75	2.50	2.25	2.25	2.00	0.75	1.50	1.50

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

CellaVision CEVI.ST · SEK

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology